Stock FPLB FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Fisher & Paykel Healthcare Corporation Limited Deutsche Boerse AG

Equities

FPLB

NZFAPE0001S2

Market Closed - Deutsche Boerse AG
Other stock markets
 02:10:08 2024-06-28 am EDT 		5-day change 1st Jan Change
16.7 EUR 0.00% Intraday chart for Fisher & Paykel Healthcare Corporation Limited -1.18% +26.52%
May. 29 Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2025 CI
May. 29 Fisher & Paykel Healthcare Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Evolution of the average Target Price on Fisher & Paykel Healthcare Corporation Limited

Price target over the last 5 years

History of analyst recommendation changes

ab38017b3b53e77f33f414.FYG490LLCdZ7S6d8oI_zx6faQnAMgqyD1rW3pVbxf28.VMbJxxKEZJgtHOMO68K-s8OgHUdor-blvPHb8xm1KzpC-9ewdZ8kjxQg8g~ead829a5d7f08ef4be2e7853d8480945

Analyst Recommendations on Fisher & Paykel Healthcare Corporation Limited

JPMorgan Upgrades Fisher & Paykel Healthcare to Neutral from Underweight; Price Target is NZ$24.00 MT
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to NZ$24.12 From NZ$23.12, Keeps at Equalweight MT
Morgan Stanley Adjusts Fisher & Paykel Healthcare’s Price Target to AU$22.19 From AU$21.50, Keeps at Equalweight MT
UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$17.70 From NZ$18.40, Keeps at Sell MT
UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$18.4 From NZ$21.9, Keeps at Sell MT
Australia shares rise; New Zealand falls as cenbank hikes rate RE
UBS Adjusts Fisher & Paykel Healthcare's Price Target to NZ$21.90 From NZ$23.50, Keeps at Sell MT
Fisher & Paykel Healthcare : F&P Healthcare Raises Guidance as Pandemic Boosts Sales to Hospitals --Update DJ
Fisher & Paykel Healthcare : F&P Healthcare Raises Guidance as Pandemic Boosts Sales to Hospitals DJ
National Australia Bank : Australia shares wobble ahead of cenbank rate decision; NZ falls RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
30.08 NZD
Average target price
25.95 NZD
Spread / Average Target
-13.73%
High Price Target
32.8 NZD
Spread / Highest target
+9.04%
Low Price Target
20.14 NZD
Spread / Lowest Target
-33.05%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Fisher & Paykel Healthcare Corporation Limited

JPMorgan
Morgan Stanley
UBS

Ratings for Fisher & Paykel Healthcare Corporation Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. FPH Stock
  4. FPLB Stock
  5. Consensus Fisher & Paykel Healthcare Corporation Limited